CDTX
Cidara Therapeutics is a biotechnology company focused on developing targeted immunotherapies to improve outcomes for patients with serious diseases. The company emphasizes its Cloudbreak platform, which creates drug-Fc conjugates by attaching targeted small molecules and peptides to a human antibody fragment to engage both disease targets and the immune system. Its pipeline includes clusters in immuno-oncology and influenza, reflecting a focus on therapies that combine precision targeting with immune engagement, and the company is headquartered in San Diego, California.